Recent discoveries highlighted a correlation between BMAL1 overexpression and a decrease in glioma invasiveness, through the inhibition of PI3K/AKT/matrix metalloproteinase-2 signaling pathway [9]. The gene discussed is BMAL1; the disease is glioma.